1. Home
  2. PTCT vs ITGR Comparison

PTCT vs ITGR Comparison

Compare PTCT & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • ITGR
  • Stock Information
  • Founded
  • PTCT 1998
  • ITGR 1970
  • Country
  • PTCT United States
  • ITGR United States
  • Employees
  • PTCT N/A
  • ITGR N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PTCT Health Care
  • ITGR Health Care
  • Exchange
  • PTCT Nasdaq
  • ITGR Nasdaq
  • Market Cap
  • PTCT 3.7B
  • ITGR 4.1B
  • IPO Year
  • PTCT 2013
  • ITGR 2000
  • Fundamental
  • Price
  • PTCT $48.52
  • ITGR $118.79
  • Analyst Decision
  • PTCT Buy
  • ITGR Strong Buy
  • Analyst Count
  • PTCT 13
  • ITGR 10
  • Target Price
  • PTCT $62.31
  • ITGR $145.90
  • AVG Volume (30 Days)
  • PTCT 1.6M
  • ITGR 522.4K
  • Earning Date
  • PTCT 05-06-2025
  • ITGR 07-24-2025
  • Dividend Yield
  • PTCT N/A
  • ITGR N/A
  • EPS Growth
  • PTCT N/A
  • ITGR N/A
  • EPS
  • PTCT 7.51
  • ITGR 2.18
  • Revenue
  • PTCT $1,772,758,000.00
  • ITGR $1,746,192,000.00
  • Revenue This Year
  • PTCT $99.06
  • ITGR $11.03
  • Revenue Next Year
  • PTCT N/A
  • ITGR $7.29
  • P/E Ratio
  • PTCT $6.46
  • ITGR $53.75
  • Revenue Growth
  • PTCT 91.12
  • ITGR 10.19
  • 52 Week Low
  • PTCT $28.72
  • ITGR $104.93
  • 52 Week High
  • PTCT $58.38
  • ITGR $146.36
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 55.25
  • ITGR 47.14
  • Support Level
  • PTCT $44.54
  • ITGR $116.87
  • Resistance Level
  • PTCT $49.15
  • ITGR $121.84
  • Average True Range (ATR)
  • PTCT 1.72
  • ITGR 2.48
  • MACD
  • PTCT 0.48
  • ITGR -0.16
  • Stochastic Oscillator
  • PTCT 87.67
  • ITGR 32.16

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

Share on Social Networks: